BIOLASE Technology, Inc. (NASDAQ: BLTI), the World’s leading dental laser manufacturer and distributor, today announced that the U.S. Patent and Trademark Office has issued BIOLASE a new patent covering the use of its laser technologies for treating va…
Clustering Gene Expression Changes Reveals Pathways Toward Glaucoma Prevention
Glaucoma is the second-most common cause of blindness in the US, and occurs due to loss of retinal ganglion cells and degeneration of the optic nerve. Although it is known that high levels of pressure within the eye predispose individuals to the develo…
Feed Flipper – Non-iTunes RSS URL Found!
Feed Flipper has discovered a non-iTunes RSS version of the “MedscapeCME Ophthalmology Podcast” podcast!
Subscribe to the URL below and remove your dependence on Feed Flipper–just don’t forget to follow us on Facebook first so can stay up to date w…
Feed Flipper – Non-iTunes RSS URL Found!
Feed Flipper has discovered a non-iTunes RSS version of the “MedscapeCME Ophthalmology Podcast” podcast!
Subscribe to the URL below and remove your dependence on Feed Flipper–just don’t forget to follow us on Facebook first so can stay up to date w…
Research Fraud: An Editor’s Responsibility?
In the wake of the autism controversy, pediatric psychiatrist and journal editor Dr. Fred Volkmar discusses the roles and responsibilities of editors in vetting the information they publish. Medscape Psychiatry & Mental Health
Aerie Pharmaceuticals closes $30 million Series B financing
Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing.